FindTrial
Sign In

Potential Carcinogenic Effects of Endovenous Laser Ablation

Potential Carcinogenic Effects of Endovenous Laser Ablation - POCEELA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36015
Enrollment
Unknown
Registered
2011-08-08
Start date
2011-12-12
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

potential carcinogenic substances during laser treatment

Interventions

None listed

Sponsors

Sint Franciscus Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients with venous disease and an indication for endovenous laser ablation - 10 smokers - 10 non-smokers

Exclusion criteria

Exclusion criteria: All patients who already had an endovenous laser ablation.

Design outcomes

Primary

MeasureTime frame
The concentration of benzo[a]pyrene before and after endovenous laser ablation.—

Secondary

MeasureTime frame
none—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)